Caption Management, LLC Argenx Se Call Options Transaction History

Caption Management, LLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$434.22 - $551.9 $3.95 Million - $5.02 Million	9,100 Added 16.05%	65,800 $35.7 Million
Q2 2024 Aug 14, 2024	BUY	$356.01 - $451.55 $20.2 Million - $25.6 Million	56,700 New	56,700 $24.4 Million
Q4 2023 Feb 14, 2024	SELL	$338.91 - $506.01 $37.6 Million - $56.2 Million	-111,000 Reduced 89.16%	13,500 $5.14 Million
Q3 2023 Nov 14, 2023	BUY	$369.35 - $548.43 $9.05 Million - $13.4 Million	24,500 Added 24.5%	124,500 $61.2 Million
Q2 2023 Aug 14, 2023	BUY	$360.14 - $422.58 $30.8 Million - $36.1 Million	85,500 Added 589.66%	100,000 $39 Million
Q1 2023 May 15, 2023	BUY	$334.23 - $403.65 $4.85 Million - $5.85 Million	14,500 New	14,500 $5.4 Million
Q2 2022 Aug 15, 2022	SELL	$269.58 - $378.88 $4.04 Million - $5.68 Million	-15,000 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$254.45 - $351.06 $3.82 Million - $5.27 Million	15,000 New	15,000 $4.73 Million
Q3 2021 Nov 12, 2021	SELL	$295.0 - $350.58 $8.85 Million - $10.5 Million	-30,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$257.11 - $319.92 $2.57 Million - $3.2 Million	10,000 Added 50.0%	30,000 $9.03 Million
Q3 2020 Nov 16, 2020	SELL	$215.51 - $272.51 $2.35 Million - $2.97 Million	-10,900 Reduced 35.28%	20,000 $5.25 Million
Q2 2020 Aug 14, 2020	BUY	$127.44 - $232.72 $3.94 Million - $7.19 Million	30,900 New	30,900 $6.96 Million

400

30.9M

376K

489K

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $31.2B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.